These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer. Tang CK, Gong XQ, Moscatello DK, Wong AJ, Lippman ME. Cancer Res; 2000 Jun 01; 60(11):3081-7. PubMed ID: 10850460 [Abstract] [Full Text] [Related]
23. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Huang Y, Li X, Jiang J, Frank SJ. Oncogene; 2006 Dec 07; 25(58):7565-76. PubMed ID: 16785991 [Abstract] [Full Text] [Related]
24. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. O-charoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM, Eccles SA. Cancer Res; 2000 Feb 15; 60(4):1121-8. PubMed ID: 10706134 [Abstract] [Full Text] [Related]
29. Ligand-independent tyrosine phosphorylation of EGF receptor and the erbB-2/neu proto-oncogene product is induced by hyperosmotic shock. King CR, Borrello I, Porter L, Comoglio P, Schlessinger J. Oncogene; 1989 Jan 15; 4(1):13-8. PubMed ID: 2464783 [Abstract] [Full Text] [Related]
31. Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells. Daly JM, Jannot CB, Beerli RR, Graus-Porta D, Maurer FG, Hynes NE. Cancer Res; 1997 Sep 01; 57(17):3804-11. PubMed ID: 9288791 [Abstract] [Full Text] [Related]
32. Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo. Yang D, Kuan CT, Payne J, Kihara A, Murray A, Wang LM, Alimandi M, Pierce JH, Pastan I, Lippman ME. Clin Cancer Res; 1998 Apr 01; 4(4):993-1004. PubMed ID: 9563895 [Abstract] [Full Text] [Related]
33. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers. Maegawa M, Takeuchi K, Funakoshi E, Kawasaki K, Nishio K, Shimizu N, Ito F. Mol Cancer Res; 2007 Apr 01; 5(4):393-401. PubMed ID: 17426253 [Abstract] [Full Text] [Related]
34. Type I growth factor receptors: current status and future work. Gullick WJ. Biochem Soc Symp; 1998 Apr 01; 63():193-8. PubMed ID: 9513723 [Abstract] [Full Text] [Related]
35. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175. Schaefer G, Fitzpatrick VD, Sliwkowski MX. Oncogene; 1997 Sep 18; 15(12):1385-94. PubMed ID: 9333014 [Abstract] [Full Text] [Related]
36. Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868. Simpson BJ, Bartlett JM, Macleod KG, Rabiasz G, Miller EP, Rae AL, Gordge P, Leake RE, Miller WR, Smyth J, Langdon SP. Br J Cancer; 1999 Mar 18; 79(7-8):1098-103. PubMed ID: 10098742 [Abstract] [Full Text] [Related]
37. Regulation of cyclooxygenase-2 pathway by HER2 receptor. Vadlamudi R, Mandal M, Adam L, Steinbach G, Mendelsohn J, Kumar R. Oncogene; 1999 Jan 14; 18(2):305-14. PubMed ID: 9927187 [Abstract] [Full Text] [Related]
38. Monoclonal antibodies to the EGF receptor act as betacellulin antagonists. Modjtahedi H, Dean C. Biochem Biophys Res Commun; 1996 Apr 25; 221(3):625-30. PubMed ID: 8630011 [Abstract] [Full Text] [Related]
39. Differential distributions of peptides in the epidermal growth factor family and phosphorylation of ErbB 1 receptor in adult rat brain. Piao YS, Iwakura Y, Takei N, Nawa H. Neurosci Lett; 2005 Dec 16; 390(1):21-4. PubMed ID: 16129559 [Abstract] [Full Text] [Related]
40. Neu and its ligands: from an oncogene to neural factors. Peles E, Yarden Y. Bioessays; 1993 Dec 16; 15(12):815-24. PubMed ID: 7908191 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]